ShockWave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W9M

181.88

-0.15

(-0.09%)

As of 01:49PM EST. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	182.04
Open	181.37
Bid	182.83 x 800
Ask	183.41 x 800
Day's Range	179.48 - 186.75
52 Week Range	113.36 - 320.54
Volume	175,723
Avg. Volume	459,081

Market Cap	6.574B
Beta (5Y Monthly)	0.97
PE Ratio (TTM)	78.06
EPS (TTM)	2.33
Earnings Date	Feb 16, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	243.25

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-26% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SWAV

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

ShockWave Medical, Inc.
SWAV: Lowering target price to $197.00SHOCKWAVE MEDICAL INC has an Investment Rating of HOLD; a target price of $197.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
6 days agoArgus Research

All

Zacks
Shockwave Medical (SWAV) Moves to Buy: Rationale Behind the Upgrade
Shockwave Medical (SWAV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Las Vegas Sands (LVS) Upgraded to Strong Buy: What Does It Mean for the Stock?
  Zacks
- All You Need to Know About American Eagle (AEO) Rating Upgrade to Strong Buy
  Zacks
Insider Monkey
ShockWave Medical (SWAV) Stock Declined in Q4 Amid Extraordinary Revenue Growth
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
GlobeNewswire
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not RecommendedSANTA CLARA, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced that coronary IVL was included in a treatment guidance document published by the Society of Cardiovascular Angiography and Intervention